Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial

This publication has 52 references indexed in Scilit:

• Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
  Blood, 2009
• Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
  Clinical Pharmacology & Therapeutics, 2009
• Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
  Clinical Cancer Research, 2009
• Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
  Blood, 2008
• Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone
  Bone Marrow Transplantation, 2007
• Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
  Transplantation and Cellular Therapy, 2007
• Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
  Seminars in Liver Disease, 2002
• IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
  British Journal of Haematology, 1997
• Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms
  Hepatology, 1994
• Isolation and Identification of Aptamers from Defibrotide That Act as Thrombin Antagonists in Vitro
  Biochemical and Biophysical Research Communications, 1994